After-Hours Movers 02/27: (ERT) (ZAGG) (PCLN) Higher; (PEIX) (ICAD) (DUF) Lower

February 27, 2012 5:54 PM EST Send to a Friend
Pacific Ethanol (NASDAQ: PEIX) 28% LOWER; reported Q4 EPS of ($0.03), versus ($1.00) reported last year. Revenue for the quarter came in at $241.8 million, versus $134.2 million reported last year.

eResearch Technology Inc. (NASDAQ: ERT) 14% HIGHER; reported Q4 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $52.3 million versus the consensus estimate of $47.52 million. Sees Q1 2012 EPS of $0.08-$0.11, versus the consensus of $0.10. Sees Q1 2012 revenue of $46-$49 million, versus the consensus of $44.73 million. Sees FY2012 EPS of $0.45-$0.53, versus the consensus of $0.46. Sees FY2012 revenue of $195-$203 million, versus the consensus of $195.16 million.

Zagg Inc. (NASDAQ: ZAGG) 7% HIGHER; reported Q4 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $67.5 million versus the consensus estimate of $63.97 million. Sees FY2012 revenue of $250 million, versus the consensus of $240.6 million.

Icad, Inc. (NASDAQ: ICAD) 7% LOWER; reported Q4 EPS of ($0.04), versus $0.00 reported last year. Revenue for the quarter came in at $6.6 million, versus $6.4 million reported last year.

Duff & Phelps Corporation (NYSE: DUF) 6.8% LOWER; has commenced an underwritten public offering of 4,500,000 shares of its common stock. Duff & Phelps is offering 3,201,922 shares in the offering and Shinsei Bank, Limited is offering an additional 1,298,078 shares as a selling stockholder. The Company and the selling stockholder will grant the underwriter a 30-day option to purchase up to an additional 675,000 shares. Goldman, Sachs & Co. is acting as the sole underwriter for the offering.

Priceline.com, Inc. (NASDAQ: PCLN) 6.3% HIGHER; reported Q4 EPS of $5.37, $0.32 better than the analyst estimate of $5.05. Revenue for the quarter came in at $991 million versus the consensus estimate of $967.91 million. Sees Q112 EPS of $3.80-$3.90, versus the consensus of $3.72.

AtriCure, Inc. (NASDAQ: ATRC) 5.8% LOWER; reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $17.16 million.

Sina Corp (NASDAQ: SINA) 4.3% LOWER; reported Q4 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $128.7 million versus the consensus estimate of $129.34 million. Sees Q1 2012 revenue of $101-$104 million, versus the consensus of $113.7 million.

ONEOK Partners, L.P. (NYSE: OKS) 3.7% LOWER; announced a public offering of 7.0 million of its common units, representing limited partner interests, subject to market and other conditions. The units will be offered by ONEOK Partners pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission. In addition, the partnership will concurrently sell 7.0 million of its common units to ONEOK, Inc. (NYSE: OKE) in a private placement.

Human Genome Sciences, Inc. (NASDAQ: HGSI) 2.8% HIGHER; reported Q4 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $45.5 million versus the consensus estimate of $42.65 million.

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) 2.5% HIGHER; reported Q4 EPS of $1.17, $0.08 better than the analyst estimate of $1.09. Revenue for the quarter came in at $83.5 million versus the consensus estimate of $80.84 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers

Add Your Comment